Cancer Health Treatment Update COVID-19 Treatment, PEP and PrEP Some people undergoing cancer treatment do not respond well to COVID-19 vaccines—but there are alternatives. Nubeqa Extends Survival for Some People With Metastatic Prostate Cancer A large clinical trial found that adding darolutamide to two other therapies increased survival for people with advanced prostate cancer. Antibody-Drug Conjugate Leads to Remission in a Third of People With Resistant Ovarian Cancer A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors. He Likes Big Butts—and Colorectal Cancer Awareness Too! “Baby Got Back” rapper Sir Mix-A-Lot releases “Bit Butts” NFTs and raises funds for the Colorectal Cancer Alliance. Advertisement FDA Approves Second COVID Booster for People 50 and Older Immunocompromised people ages 12 and older are also eligible for an additional shot. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Spring 2022 Check out our latest print edition! Newsfeed He Likes Big Butts—and Colorectal Cancer Awareness Too! Rising Star Researcher Changes Black Attitudes Toward End-of-Life Cancer Care Artificial Sweeteners Linked to Increased Cancer Risk “Many Cancers Have Gone Undetected Due to the COVID-19 Pandemic” Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed He Likes Big Butts—and Colorectal Cancer Awareness Too! Rising Star Researcher Changes Black Attitudes Toward End-of-Life Cancer Care Artificial Sweeteners Linked to Increased Cancer Risk “Many Cancers Have Gone Undetected Due to the COVID-19 Pandemic” Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: